Analyst price target range
Maravai LifeSciences Holdings Price Target: $7.42 Average
Direct answer
Maravai LifeSciences Holdings's average price target is $7.42.
The verified analyst range runs from $6.50 to $8.00.
The low target implies -14.5%, the high target implies +5.3%, and the range spans 19.7% of the current price.
Forecast evidence checked September 26, 2026.
Get free Maravai LifeSciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.60
- Average price target
- $7.42
- High price target
- $8.00
- Low price target
- $6.50
- Low target gap
- -14.5%
- Target upside
- -2.4%
- High target gap
- +5.3%
- Target range width
- 19.7%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- September 26, 2026
- Valid through
- October 3, 2026
Explore related company data
Read the frequently asked questions.
What is Maravai LifeSciences Holdings's average price target?
Maravai LifeSciences Holdings's verified average price target is $7.42. The target range is $6.50 to $8.00.
How far are Maravai LifeSciences Holdings's low and high targets from the recorded price?
The low target implies -14.5%, while the high target implies +5.3%.
How many analysts are included in Maravai LifeSciences Holdings's consensus?
The verified consensus includes 6 analysts.
How is Maravai LifeSciences Holdings's target upside or downside calculated?
The average target of $7.42 is divided by the recorded price of $7.60, then one is subtracted to produce -2.4%. This does not guarantee a future return.
When was Maravai LifeSciences Holdings's analyst forecast verified?
The data was verified on 2026-09-26. The dataset is valid through 2026-10-03.